- Home
- Your Messages
-
Smartest Doc
Test your clinical knowledge against other physicians in the USA by taking our FREE daily quiz!
We invite you to take the "Glomerular disease Quiz"
Current Top Players:
1) Dr. Bamidele Ajibola
2) Dr. Ambrosio Romero
3) Dr. A Rosario
>> Live LeaderboardNew! PHYSICIAN REVIEW
Assess your general knowledge at the topic level with your personalized scorecard.
Thousands of multiple-choice questions pinpoint your areas of expertise and prep you for exams.
- Physician Jobs (121)
- More
- Other Specialty
Nephrology - Hematology/Oncology News & Articles
MDLinx Nephrology is the one place you can find the most updated medical journal articles that focus on topics such as: kidney function, renal replacement therapy, immunosuppression management, clinical pharmacology, chronic kidney disease and much more. The articles found on MDLinx are thoroughly classified and expertly summarized by our team of medical editors, and then ranked to provide you optimal value for your time.
As a bonus you can check out our “must read” articles highlighted by our physician editor, D. Scott Cunningham, MD, PhD, along with clinical pearls from The Smartest Nephrologist daily quiz competition and review.
Become a member and get exclusive access to Nephrology career opportunities, e-newsletters that keep you updated with the latest medical literature, Category 1 & 2 CME credit opportunities as well as the ability to earn honoraria by participating in Market Research studies.
Your Unread Messages in Nephrology
See All >> Messages include industry-sponsored communications and special communications from MDLinx-
Smartest Doc Challenge
MDLinx
Clinical Pearls for Nephrologists -
MDLinx Reminder
MDLinx
Conference Center Upgraded with New Tools -
MDLinx Top Read
MDLinx
Running from that pile of unread journals? -
Articles
Latest (3) Full Text Articles (117) Focus on Cystic Kidney Disease21 Long-term survivor of relapsed stage IV malignant rhabdoid tumor of the kidney Pediatrics International, May 2, 2013
22 Older renal cell cancer patients experience increased rates of venous thromboembolic events: a retrospective cohort study of SEER-Medicare data Full Text BMC Cancer, May 1, 2013 Clinical Article
23 Identification of the transcription factor HOXB4 as a novel target of miR-23a Genes, Chromosomes and Cancer, May 1, 2013 Clinical Article
24 CXC chemokine receptor 4 is essential for maintenance of renal cell carcinoma-initiating cells and predicts metastasis Stem Cells, May 1, 2013 Review Article
25 Renal epithelioid angiomyolipoma with a negative premelanosome marker immunoprofile: a case report and review of the literature Full Text Journal of Medical Case Reports, April 30, 2013
26 The progression free survival-plateau with vascular endothelial growth factor receptor inhibitors-Is there more to come European Journal of Cancer, April 30, 2013 Clinical Article
27 Segmental Enhancement Inversion of Small Renal Oncocytoma: Differences in Prevalence According to Tumor Size American Journal of Roentgenology, April 30, 2013 Clinical Article
28 Prolonged exposure to tyrosine kinase inhibitors or early use of everolimus in metastatic renal cell carcinoma: are the two options alike Medical Oncology, April 29, 2013 Clinical Article
29 A report of renal artery embolization for hematuria facilitating neoadjuvant chemotherapy in an unresectable malignant renal rhabdoid tumor Pediatric Surgery International, April 29, 2013
30 Collecting duct carcinoma: A rare malignancy Journal of Cancer Research and Therapeutics, April 29, 2013
31 Adverse Outcomes in Clear Cell Renal Cell Carcinoma with Mutations of 3p21 Epigenetic Regulators BAP1 and SETD2: a Report by MSKCC and the KIRC TCGA Research Network Clinical Cancer Research, April 26, 2013 Clinical Article
32 Clinical outcomes in patients receiving three lines of targeted therapy for metastatic renal cell carcinoma: Results from a large patient cohort European Journal of Cancer, April 25, 2013 Clinical Article
33 Second line treatment of metastatic renal cell carcinoma: The Institut Gustave Roussy experience with targeted therapies in 251 consecutive patients European Journal of Cancer, April 25, 2013 Clinical Article
34 A Phase I Study of Folate Immune Therapy (EC90 Vaccine Administered With GPI-0100 Adjuvant Followed by EC17) in Patients With Renal Cell Carcinoma Journal of Immunotherapy, April 25, 2013 Clinical Article
35 Renal Lipoma: a case report Central European Journal of Medicine, April 25, 2013
36 Mucinous tubular and spindle cell carcinoma of the kidney with sarcomatoid transformation Full Text Saudi Journal of Kidney Diseases and Transplantation, April 25, 2013
37 Renal cell neoplasm of oncocytosis: a type of unclassified renal cell carcinoma Clinical and Experimental Nephrology Case Reports, April 24, 2013
38 Activation of HIF2α in Kidney Proximal Tubule Cells Causes Abnormal Glycogen Deposition but not Tumorigenesis Cancer Research, April 24, 2013 Clinical Article
39 Renal Cell Carcinoma: Role of MR Imaging in the Assessment of Muscular Venous Branch Invasion Radiology, April 23, 2013 Clinical Article
40 Reduced mrna expression level of corticotropin-releasing hormone-binding protein is associated with aggressive human kidney cancer Full Text BMC Cancer, April 23, 2013 Clinical Article
Clinical Pearls in Nephrology
- In patients with acute myocardial infarction, the hazard ratio (HR) for major adverse cardiac and cerebrovascular events (MACCE) was highest in patients with chronic kidney disease and anemia.
- Well-managed use of tobramycin long term is not associated with kidney failure. In a retrospective study among individuals with cystic fibrosis, the use of intravenous colistin, gentamicin, tobramycin or vancomycin did not correlate with increased BUN or creatinine after 8.5 years. Furthermore, only inhaled colistin correlated with kidney failure episodes
- Evidence by the Study of Heart and Renal Protection trial showed cardiovascular benefit and absence of special safety concerns for statin administration in chronic kidney disease; yet some experts call for additional data on renal outcomes.
Highlights in Nephrology
Risk factors for acute cardiac events in patients with community-acquired pneumonia
As published in the Journal of Infection, patients with community-acquired pneumonia (CAP) and acute cardiac events (ACEs) have a higher fatality rate (19.4%) than patients with CAP but without ACEs (6.4%). Of 3291 patients with CAP over a 15-year period, 315 had ACEs (8%; arrhythmias, n=199; congestive heart failure, n=118; myocardial infarction, n=30). Based on multivariate analysis, chronic heart disease, chronic kidney disease, tachycardia, septic shock, multilobar pneumonia, hypoalbuminemia, and pneumococcal pneumonia were associated with ACEs in patients with CAP.
Read the article summarySerum amyloid A is a sensitive biomarker for advanced renal cancer
Researchers from Martin Luther University Halle-Wittenberg (Germany) have reported that serum amyloid A (SAA) has greater sensitivity in detecting advanced renal tumors than CRP or IL-6 levels. Specifically, the sensitivities and specificities of SAA, CRP, and IL-6 for advanced renal tumors were 78%, 69%, and 44%, and 82%, 82%, and 94%, respectively. Furthermore, the SAA levels were higher in patients with advanced renal tumors than patients with localized renal tumors.
Read the article summaryNSAID-associated AKI more severe in young children
As published in the Journal of Pediatrics, NSAID-associated acute tubular necrosis and acute interstitial nephritis occurred in 21 and 6 of 1015 children with acute kidney injuries, respectively. Correct dosing of NSAIDs was confirmed in 75% of the children. Children < 5 years of age had more severe disease, more often requiring dialysis (100% vs. 0) and ICU admission (75% vs. 9%), and increased length of stay (10 d vs. 7 d).
Read the article summaryMost Popular Nephrology Articles
Last month's top read Top Articles of 20121 Uric Acid Levels Correlate with Baseline Renal Function and High Levels are a Potent Risk Factor for Postoperative Chronic Kidney Disease in Patients with Renal Cell Carcinoma The Journal of Urology, April 15, 2013
2 Is consumption of vegetables and fruit a protective factor against kidney cancer Central European Journal of Medicine, April 22, 2013
3 Angiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell disease Cochrane Reviews, April 1, 2013 Review Article
4 Bosniak IIF renal cysts: is there a malignancy potential Journal of Clinical Urology, April 1, 2013
5 Adverse Outcomes in Clear Cell Renal Cell Carcinoma with Mutations of 3p21 Epigenetic Regulators BAP1 and SETD2: a Report by MSKCC and the KIRC TCGA Research Network Clinical Cancer Research, April 26, 2013
6 The tumor suppressive function of UNC5D and its repressed expression in renal cell carcinoma Clinical Cancer Research, April 17, 2013 Review Article
7 Renal Medullary Carcinoma: Molecular, Immunohistochemistry, and Morphologic Correlation American Journal of Surgical Pathology , March 5, 2013
8 Prolonged exposure to tyrosine kinase inhibitors or early use of everolimus in metastatic renal cell carcinoma: are the two options alike Medical Oncology, April 29, 2013
9 Renal Cell Carcinoma: Role of MR Imaging in the Assessment of Muscular Venous Branch Invasion Radiology, April 23, 2013
10 Tetrandrine triggers apoptosis and cell cycle arrest in human renal cell carcinoma cells Journal of Natural Medicines, April 8, 2013
11 Patient-reported outcomes for axitinib vs sorafenib in metastatic renal cell carcinoma: phase III (AXIS) trial British Journal of Cancer, April 12, 2013
12 Clinical outcomes in patients receiving three lines of targeted therapy for metastatic renal cell carcinoma: Results from a large patient cohort European Journal of Cancer, April 25, 2013
13 Renal cell neoplasm of oncocytosis: a type of unclassified renal cell carcinoma Clinical and Experimental Nephrology Case Reports, April 24, 2013
14 Differential Diagnosis of Renal Tumors With Clear Cytoplasm: Clinical Relevance of Renal Tumor Subclassification in the Era of Targeted Therapies and Personalized Medicine Archives of Pathology & Laboratory Medicine, April 2, 2013 Free full text
15 Sequencing of Agents for Metastatic Renal Cell Carcinoma: Can We Customize Therapy European Urology, January 27, 2012 Free full text
16 Oral Adverse Events Associated with Tyrosine Kinase and Mammalian Target of Rapamycin Inhibitors in Renal Cell Carcinoma The Oncologist, January 30, 2012 Free full text
17 Indocyanine green (ICG)-based fluorescence navigation system for discrimination of kidney cancer from normal parenchyma: application during partial nephrectomy International Urology and Nephrology, January 13, 2012
18 Baseline quality of life as a prognostic survival tool in patients receiving sunitinib for metastatic renal cell carcinoma British Journal of Cancer, January 13, 2012
19 Efficacy and safety of vascular endothelial growth factor receptor tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma and poor risk features Journal of Cancer Research & Clinical Oncology, January 19, 2012
20 T Lymphocyte Recruitment into Renal Cell Carcinoma Tissue: A Role for Chemokine Receptors CXCR3, CXCR6, CCR5, and CCR6 European Urology, January 30, 2012 Free full text
Indexed Journals in Nephrology: Kidney International, Hemodialysis International, Nephrology Dialysis Transplantation more
Other Topics in Nephrology
Register now to view all the MDLinx contents (FREE)!
- Stay current on the latest literature, research and clinical news
- Get special communications and offers from MDLinx and our sponsors
- Receive invitations to paid market research
Login
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close